询 价
索取COA
产品描述
产品数据库
Introduction | |||||
Format | Genomic DNA | ||||
Description | CYP2D6, cytochrome P450 family 2 subfamily D member 6, is a member of the cytochrome P450 family of monooxygenases that catalyzes drug metabolism (PMID: 28480783). CYP2D6 variants have been associated with risks of various cancers (PMID: 22994728, PMID: 16550168) and may alter the metabolism of tamoxifen in breast cancer patients. | ||||
Technical Data | |||||
Gene | CYP2D6 | ||||
Mutation Type 1 | AA Change: N/A | ||||
DNA Change: NM_000106.6:c.985+39G>A | |||||
Chr position (GRCh38):chr22:42127803 | |||||
Mutation Type 2 | AA Change: p.R296C | ||||
DNA Change: NM_000106.6:c.886C>T | |||||
Chr position (GRCh38):chr22:42127941 | |||||
Mutation Type 3 | AA Change: N/A | ||||
DNA Change: NM_000106.6:c.408G>C | |||||
Chr position (GRCh38):chr22:42129130 | |||||
Mutation Type 4 | AA Change: p.S486T | ||||
DNA Change: NM_000106.6:c.1457G>C | |||||
Chr position (GRCh38):chr22:42126611 | |||||
Allelic Frequency | 50% | ||||
Zygosity | Heterozygous | ||||
Product Information | |||||
Intended Use | Research Use Only | ||||
Unit Size | 1ug | ||||
Concentration | Download for COA | ||||
Purofication | Download for COA | ||||
DNA electrophoresis | Download for COA | ||||
Sanger sequencing |
Figure 1. CYP2D6*41 Reference Standard c.985+39G>A
Figure 2. CYP2D6*41 Reference Standard p.R296C
Figure 3. CYP2D6*41 Reference Standard c.408G>C Figure 4. CYP2D6*41 Reference Standard p.S486T |
||||
Storage | 2-8°C | ||||
Expiry | 36 months from the date of manufacture |